GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

25 hedge funds and large institutions have $35.4M invested in Galmed Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
8
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$9.91M
2
RJA
2
Raymond James & Associates
Florida
$2.56M
3
AIM
3
ARK Investment Management
Florida
$1.11M
4
PF
4
Phoenix Financial
Israel
$611K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$373K

Top Sellers

1
6CM
1
683 Capital Management
New York
$0
2
RCG
2
Rock Creek Group
District of Columbia
$0
3
BI
3
BVF Inc
California
$8.6M
4
VC
4
Voss Capital
Texas
$640K
5
Squarepoint
5
Squarepoint
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
6CM
26
683 Capital Management
New York
– -$2.71M -4,343 Closed
RCG
27
Rock Creek Group
District of Columbia
– -$327K -525 Closed
Squarepoint
28
Squarepoint
New York
– -$119K -191 Closed
Millennium Management
29
Millennium Management
New York
– -$82K -131 Closed
Goldman Sachs
30
Goldman Sachs
New York
– -$62K -99 Closed
TSS
31
Two Sigma Securities
New York
– -$57K -91 Closed
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
– -$8K -13 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$5K -9 Closed
1
2